TTTY20

Across TCGA pan-cancer cohorts, TTTY20 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated TTTY20 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher TTTY20 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TTTY20 expression acts as an unfavorable survival marker.

KIRC, LIHC, and UCEC are the cancer types where TTTY20 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.708	0.889	<.001	144	view →
LIHC	OS	Tertile	All	0.319	0.728	<.001	90	view →
UCEC	DFS	Tertile	All	0.124	0.839	<.001	90	view →
MESO	OS	Tertile	All	0.241	0.434	.003	63	view →
THCA	DFS	Tertile	II,III,IV	0.061	0.730	<.001	36	view →
LUSC	OS	Tertile	II,III,IV	0.446	0.746	.037	18	view →
LGG	DFS	Tertile	All	0.268	0.753	.029	9	view →
STAD	DFS	Tertile	II,III,IV	0.158	0.523	.038	9	view →
SARC	OS	Tertile	All	0.631	0.871	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

TTTY20–KIRC (OS)

Open the KIRC breakdown →